FDA: Tougher warnings, dose limits for Tylenol

Drugmakers should limit doses and strengthen warnings on Johnson and Johnson's Tylenol and other medicines containing acetaminophen to reduce the risk of liver injury, according to a U.S. report. Report

Suggested Articles

The real estate impresario that built a chain of upscale drug recovery facilities is now building a gene and cell therapy CDMO near Philadelphia.

The seven-year Astellas venture served as a model for Amgen's recent $2.7 billion tie-up with BeiGene in China—and now it's amping up there, too.

After a jury ordered Gilead's Kite Pharma to pay $752 million for CAR-T patent infringement, BMS is asking for punitive damages in that amount, too.